Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 7174
TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179548(US9126979, 5)
Affinity DataIC50: 84.8nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179548(US9126979, 5)
Affinity DataIC50: 102nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179545(US9126979, 2)
Affinity DataIC50: 135nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179545(US9126979, 2)
Affinity DataIC50: 151nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179554(US9126979, 11)
Affinity DataIC50: 247nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179554(US9126979, 11)
Affinity DataIC50: 278nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179555(US9126979, 12)
Affinity DataIC50: 283nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179544(US9126979, 1)
Affinity DataIC50: 384nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179546(US9126979, 3)
Affinity DataIC50: 421nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179552(US9126979, 9)
Affinity DataIC50: 422nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179546(US9126979, 3)
Affinity DataIC50: 455nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179555(US9126979, 12)
Affinity DataIC50: 470nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179544(US9126979, 1)
Affinity DataIC50: 512nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179552(US9126979, 9)
Affinity DataIC50: 624nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179547(US9126979, 4)
Affinity DataIC50: 773nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179553(US9126979, 10)
Affinity DataIC50: 892nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179547(US9126979, 4)
Affinity DataIC50: 1.27E+3nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179550(US9126979, 7)
Affinity DataIC50: 1.28E+3nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179549(US9126979, 6)
Affinity DataIC50: 1.29E+3nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179553(US9126979, 10)
Affinity DataIC50: 1.53E+3nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179550(US9126979, 7)
Affinity DataIC50: 1.54E+3nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179551(US9126979, 8)
Affinity DataIC50: 1.72E+3nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179549(US9126979, 6)
Affinity DataIC50: 2.09E+3nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179551(US9126979, 8)
Affinity DataIC50: 2.94E+3nMT: 2°CAssay Description:The SPR assay is configured to examine solution inhibition of BCL-2 binding to peptide derivatized sensor surfaces to generate IC50 values as a measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent